• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.20% Nasdaq Up 0.38%

    Acorda Therapeutics, Inc. (ACOR)

    -NasdaqGS
    26.95 Up 0.85(3.26%) Mar 29, 4:00PM EDT
    Prev Close:26.10
    Open:26.10
    Bid:22.00 x 300
    Ask:N/A
    1y Target Est:34.40
    Beta:1.47451
    Earnings Date:Apr 26 - May 1 (Est.)
    Day's Range:25.55 - 29.75
    52wk Range:16.40 - 33.00
    Volume:1,259,007
    Avg Vol (3m):863,623
    Market Cap:1.25B
    P/E (ttm):N/A
    EPS (ttm):-0.77
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for ACOR

    Comparison

    Symbol% ChgMkt Cap
    ACORUp 3.26%1.25B
    1 0.00%N/A
    BIIBDown 2.04%57.99B

    Key Statistics

    Forward P/E (1 yr):15.67
    P/S (ttm):2.29
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-17) :1.13
    Quarterly EPS Est (Mar-17) :0.09
    Mean Recommendation*:2.3
    PEG Ratio (5 yr expected):0.78

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Acorda Therapeutics, Inc., a biopharmaceutical company, identifies, develops, and commercializes therapies for neurological disorders in the United States. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback